Vistin Pharma - Call Transcript 2023

Vistin Pharma ASA: Invitation to Q3 2023 conference call

Oslo, Norway, 18 October 2023

Vistin Pharma ASA will release its third quarter results on Wednesday 25(th) of

October 2023. Vistin Pharma will host a conference call for all shareholders and

interested parties at the same day; Wednesday 25th of October at 08:30 CET.

There will be a Q&A session following the management discussion.

The conference call will be held in English.

The third quarter conference call will be available via web and audio through

the following access points:

Webcast:

https://edge.media-server.c (https://edge.media-server.com/mmc/p/bbzmgojv)o

(https://edge.media-server.com/mmc/p/bbzmgojv)m/mmc/p/bbzmgojv

(https://edge.media-server.com/mmc/p/bbzmgojv)

Telephone conference (online registration):

https://register.vevent.co

(https://register.vevent.com/register/BIde003424d0984dc899edfd078e0f4dd9)m

(https://register.vevent.com/register/BIde003424d0984dc899edfd078e0f4dd9)/regist

er/BIde003424d0984dc899edfd078e0f4dd9

(https://register.vevent.com/register/BIde003424d0984dc899edfd078e0f4dd9)

*****

For further information, please contact:

Alexander Karlsen

CFO

+47 97053621

About Vistin Pharma | www.vistin.com

Vistin Pharma is a Norwegian pharmaceutical company producing Metformin

Hydrochloride (API). The Metformin is also available as Direct Compressible

lubricated granules. As a solely dedicated European Metformin producer, Vistin

Pharma is a well-positioned supplier to leading pharmaceutical companies. Vistin

Pharma is headquartered in Oslo, Norway, and has highly qualified employees and

a dedicated manufacturing facility in Kragerø.

AI assistant